Pathological Examination Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

CHAPTER 1. Industry Overview of Pathological Examination Market

1.1. Definition and Scope

1.1.1. Definition of Pathological Examination

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Pathological Examination Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Pathological Examination Market By Test

1.2.3. Pathological Examination Market By Service

1.2.4. Pathological Examination Market By End-User

1.2.5. Pathological Examination Market By Region

 

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

 

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.1.3. Driver 3

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.2.3. Restraint 3

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.3.3. Opportunity 3

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Pathological Examination Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Pathological Examination Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2023

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

 

CHAPTER 4. Pathological Examination Market By Test

4.1. Introduction

4.2. Pathological Examination Revenue By Test

4.2.1. Pathological Examination Revenue (USD Million) and Forecast, By Test, 2020-2032

4.2.2. Digital Pathology

4.2.2.1. Digital Pathology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3. Traditional Pathology

4.2.3.1. Traditional Pathology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 5. Pathological Examination Market By Service

5.1. Introduction

5.2. Pathological Examination Revenue By Service

5.2.1. Pathological Examination Revenue (USD Million) and Forecast, By Service, 2020-2032

5.2.2. Anatomic Pathology

5.2.2.1. Anatomic Pathology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3. Surgical Pathology

5.2.3.1. Surgical Pathology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4. Molecular Pathology

5.2.4.1. Molecular Pathology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5. Cytopathology

5.2.5.1. Cytopathology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.6. Clinical Pathology

5.2.6.1. Clinical Pathology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 6. Pathological Examination Market By Application

6.1. Introduction

6.2. Pathological Examination Revenue By Application

6.2.1. Pathological Examination Revenue (USD Million) and Forecast, By Application, 2020-2032

6.2.2. Digestive Organ

6.2.2.1. Digestive Organ Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3. Others

6.2.3.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 7. Pathological Examination Market By End-User

7.1. Introduction

7.2. Pathological Examination Revenue By End-User

7.2.1. Pathological Examination Revenue (USD Million) and Forecast, By End-User, 2020-2032

7.2.2. Hospitals

7.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3. Diagnostic Laboratories

7.2.3.1. Diagnostic Laboratories Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.4. Research Institutes

7.2.4.1. Research Institutes Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.5. Others

7.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 8. North America Pathological Examination Market By Country 

8.1. North America Pathological Examination Market Overview

8.2. U.S.

8.2.1. U.S. Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

8.2.2. U.S. Pathological Examination Revenue (USD Million) and Forecast By Service, 2020-2032

8.2.3. U.S. Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

8.2.4. U.S. Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

8.3. Canada

8.3.1. Canada Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

8.3.2. Canada Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

8.3.3. Canada Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

8.3.4. Canada Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

8.4. North America PEST Analysis

 

CHAPTER 9. Europe Pathological Examination Market By Country

9.1. Europe Pathological Examination Market Overview

9.2. U.K.

9.2.1. U.K. Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

9.2.2. U.K. Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

9.2.3. U.K. Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

9.2.4. U.K. Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

9.3. Germany

9.3.1. Germany Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

9.3.2. Germany Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

9.3.3. Germany Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

9.3.4. Germany Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

9.4. France

9.4.1. France Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

9.4.2. France Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

9.4.3. France Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

9.4.4. France Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

9.5. Spain

9.5.1. Spain Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

9.5.2. Spain Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

9.5.3. Spain Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

9.5.4. Spain Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

9.6.2. Rest of Europe Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

9.6.3. Rest of Europe Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

9.6.4. Rest of Europe Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

9.7. Europe PEST Analysis

 

CHAPTER 10. Asia Pacific Pathological Examination Market By Country

10.1. Asia Pacific Pathological Examination Market Overview

10.2. China

10.2.1. China Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

10.2.2. China Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

10.2.3. China Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

10.2.4. China Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

10.3. Japan

10.3.1. Japan Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

10.3.2. Japan Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

10.3.3. Japan Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

10.3.4. Japan Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

10.4. India

10.4.1. India Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

10.4.2. India Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

10.4.3. India Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

10.4.4. India Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

10.5. Australia

10.5.1. Australia Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

10.5.2. Australia Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

10.5.3. Australia Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

10.5.4. Australia Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

10.6. South Korea

10.6.1. South Korea Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

10.6.2. South Korea Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

10.6.3. South Korea Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

10.6.4. South Korea Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

10.7.2. Rest of Asia-Pacific Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

10.7.3. Rest of Asia-Pacific Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

10.7.4. Rest of Asia-Pacific Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

10.8. Asia Pacific PEST Analysis

 

CHAPTER 11. Latin America Pathological Examination Market By Country

11.1. Latin America Pathological Examination Market Overview

11.2. Brazil

11.2.1. Brazil Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

11.2.2. Brazil Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

11.2.3. Brazil Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

11.2.4. Brazil Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

11.3. Mexico

11.3.1. Mexico Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

11.3.2. Mexico Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

11.3.3. Mexico Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

11.3.4. Mexico Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

11.4.2. Rest of Latin America Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

11.4.3. Rest of Latin America Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

11.4.4. Rest of Latin America Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

11.5. Latin America PEST Analysis

 

CHAPTER 12. Middle East & Africa Pathological Examination Market By Country 

12.1. Middle East & Africa Pathological Examination Market Overview

12.2. GCC

12.2.1. GCC Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

12.2.2. GCC Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

12.2.3. GCC Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

12.2.4. GCC Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

12.3. South Africa

12.3.1. South Africa Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

12.3.2. South Africa Pathological Examination Revenue (USD Million) and Forecast  By Service, 2020-2032

12.3.3. South Africa Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

12.3.4. South Africa Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Pathological Examination Revenue (USD Million) and Forecast By Test, 2020-2032

12.4.2. Rest of Middle East & Africa Pathological Examination Revenue (USD Million) and Forecast By Service, 2020-2032

12.4.3. Rest of Middle East & Africa Pathological Examination Revenue (USD Million) and Forecast By Application, 2020-2032

12.4.4. Rest of Middle East & Africa Pathological Examination Revenue (USD Million) and Forecast By End-User, 2020-2032

12.5. Middle East & Africa PEST Analysis

 

CHAPTER 13. Player Analysis Of Pathological Examination Market

13.1. Pathological Examination Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Pathological Examination Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

 

CHAPTER 14. Company Profile

14.1. Sonic Healthcare Limited

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Million), 2023

14.1.3.2. Sonic Healthcare Limited, 2023 Pathological Examination Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Quest Diagnostics, Inc.

14.3. Abbott Pathology

14.4. Healio

14.5. Danaher Corporation

14.6. F. Hoffmann-La Roche Ltd

14.7. Agilient Technologies

14.8. Trinity Biotech

14.9. Apollo Diagnostics

14.10. Siemens Healthcare Private Limited